The long non‐coding RNA landscape in triple‐negative breast cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The long non‐coding RNA landscape in triple‐negative breast cancer

Published:2020-12-13 Issue:2 Volume:54 Page:
ISSN:0960-7722
Container-title:Cell Proliferation
language:en
Short-container-title:Cell Prolif

Author:

Zhang Wenwen¹^ORCID,Guan Xiaoxiang²,Tang Jinhai³

Affiliation:

1. Department of Oncology Nanjing First Hospital, Nanjing Medical University Nanjing China

2. Department of Oncology The First Affiliated Hospital of Nanjing Medical University Nanjing China

3. Department of General Surgery The First Affiliated Hospital of Nanjing Medical University Nanjing China

Funder

Natural Science Foundation of Jiangsu Province

National Natural Science Foundation of China-Guangdong Joint Fund

Publisher

Wiley

Subject

Cell Biology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cpr.12966

Reference149 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Molecular portraits of human breast tumours;Perou CM;Nature,2000

3. Prognostic markers in triple-negative breast cancer

4. Therapeutic Strategies for Triple-Negative Breast Cancer

5. Long Noncoding RNAs: Cellular Address Codes in Development and Disease

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. LncRNA XIST/miR-455-3p/HOXC4 axis promotes breast cancer development by activating TGF-β/SMAD signaling pathway;Functional & Integrative Genomics;2024-09-12

2. LncRNA HIF1A-AS2 promotes triple-negative breast cancer progression and paclitaxel resistance via MRPS23 protein;Heliyon;2024-09

3. MANCR lncRNA Modulates Cell-Cycle Progression and Metastasis by Cis-Regulation of Nuclear Rho-GEF;Molecular and Cellular Biology;2024-08-12

4. Long non-coding intergenic RNA, LINC00273 induces cancer metastasis and stemness via miRNA sponging in triple negative breast cancer;International Journal of Biological Macromolecules;2024-08

5. Management of triple-negative breast cancer by natural compounds through different mechanistic pathways;Frontiers in Genetics;2024-07-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3